Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Sharon E. Frey, David I. Bernstein, Michael A. Gerber, Harry L. Keyserling, Flor M. Munoz, Patricia L. Winokur, Christine B. Turley, Richard Rupp, Heather Hill, Mark Wolff, Diana L. Noah, Allison C. Ross, Gretchen Cress, Robert B. Belshe

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background.Administering 2 separate vaccines for seasonal and pandemic influenza was necessary in 2009. Therefore, we conducted a randomized trial of monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine) and seasonal trivalent inactivated influenza vaccine (TIV; split virion) given sequentially or concurrently in previously vaccinated children.Methods.Children randomized to 4 study groups and stratified by age received 1 dose of seasonal TIV and 2 doses of 2009 H1N1 vaccine in 1 of 4 combinations. Injections were given at 21-day intervals and serum samples for hemagglutination inhibition antibody responses were obtained prior to and 21 days after each vaccination. Reactogenicity and adverse events were monitored.Results.All combinations of vaccines were safe in the 531 children enrolled. Generally, 1 dose of 2009 H1N1 vaccine and 1 dose of TIV, regardless of sequence or concurrency of administration, was immunogenic in children ≥10 years of age; children <10 years of age required 2 doses of 2009 H1N1 vaccine.Conclusions.Vaccines were generally well tolerated. The immune responses to 2009 H1N1 vaccine were adequate regardless of the sequence of vaccination in all age groups but the sequence affected titers to TIV antigens. Two doses of 2009 H1N1 vaccine were required to achieve a protective immune response in children <10 years of age.Clinical Trials Registration.NCT00943202.

Original languageEnglish (US)
Pages (from-to)828-837
Number of pages10
JournalJournal of Infectious Diseases
Volume206
Issue number6
DOIs
StatePublished - Sep 15 2012

Fingerprint

Influenza Vaccines
Human Influenza
Vaccination
Safety
Vaccines
Age Groups
Combined Vaccines
Inactivated Vaccines
Hemagglutination
Pandemics
Virion
Antibody Formation
Clinical Trials
Antigens
Injections
Serum

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Frey, S. E., Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., ... Belshe, R. B. (2012). Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. Journal of Infectious Diseases, 206(6), 828-837. https://doi.org/10.1093/infdis/jis445

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. / Frey, Sharon E.; Bernstein, David I.; Gerber, Michael A.; Keyserling, Harry L.; Munoz, Flor M.; Winokur, Patricia L.; Turley, Christine B.; Rupp, Richard; Hill, Heather; Wolff, Mark; Noah, Diana L.; Ross, Allison C.; Cress, Gretchen; Belshe, Robert B.

In: Journal of Infectious Diseases, Vol. 206, No. 6, 15.09.2012, p. 828-837.

Research output: Contribution to journalArticle

Frey, SE, Bernstein, DI, Gerber, MA, Keyserling, HL, Munoz, FM, Winokur, PL, Turley, CB, Rupp, R, Hill, H, Wolff, M, Noah, DL, Ross, AC, Cress, G & Belshe, RB 2012, 'Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations', Journal of Infectious Diseases, vol. 206, no. 6, pp. 828-837. https://doi.org/10.1093/infdis/jis445
Frey, Sharon E. ; Bernstein, David I. ; Gerber, Michael A. ; Keyserling, Harry L. ; Munoz, Flor M. ; Winokur, Patricia L. ; Turley, Christine B. ; Rupp, Richard ; Hill, Heather ; Wolff, Mark ; Noah, Diana L. ; Ross, Allison C. ; Cress, Gretchen ; Belshe, Robert B. / Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations. In: Journal of Infectious Diseases. 2012 ; Vol. 206, No. 6. pp. 828-837.
@article{b781685218594ab9a3dc9b59718e7369,
title = "Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations",
abstract = "Background.Administering 2 separate vaccines for seasonal and pandemic influenza was necessary in 2009. Therefore, we conducted a randomized trial of monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine) and seasonal trivalent inactivated influenza vaccine (TIV; split virion) given sequentially or concurrently in previously vaccinated children.Methods.Children randomized to 4 study groups and stratified by age received 1 dose of seasonal TIV and 2 doses of 2009 H1N1 vaccine in 1 of 4 combinations. Injections were given at 21-day intervals and serum samples for hemagglutination inhibition antibody responses were obtained prior to and 21 days after each vaccination. Reactogenicity and adverse events were monitored.Results.All combinations of vaccines were safe in the 531 children enrolled. Generally, 1 dose of 2009 H1N1 vaccine and 1 dose of TIV, regardless of sequence or concurrency of administration, was immunogenic in children ≥10 years of age; children <10 years of age required 2 doses of 2009 H1N1 vaccine.Conclusions.Vaccines were generally well tolerated. The immune responses to 2009 H1N1 vaccine were adequate regardless of the sequence of vaccination in all age groups but the sequence affected titers to TIV antigens. Two doses of 2009 H1N1 vaccine were required to achieve a protective immune response in children <10 years of age.Clinical Trials Registration.NCT00943202.",
author = "Frey, {Sharon E.} and Bernstein, {David I.} and Gerber, {Michael A.} and Keyserling, {Harry L.} and Munoz, {Flor M.} and Winokur, {Patricia L.} and Turley, {Christine B.} and Richard Rupp and Heather Hill and Mark Wolff and Noah, {Diana L.} and Ross, {Allison C.} and Gretchen Cress and Belshe, {Robert B.}",
year = "2012",
month = "9",
day = "15",
doi = "10.1093/infdis/jis445",
language = "English (US)",
volume = "206",
pages = "828--837",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

AU - Frey, Sharon E.

AU - Bernstein, David I.

AU - Gerber, Michael A.

AU - Keyserling, Harry L.

AU - Munoz, Flor M.

AU - Winokur, Patricia L.

AU - Turley, Christine B.

AU - Rupp, Richard

AU - Hill, Heather

AU - Wolff, Mark

AU - Noah, Diana L.

AU - Ross, Allison C.

AU - Cress, Gretchen

AU - Belshe, Robert B.

PY - 2012/9/15

Y1 - 2012/9/15

N2 - Background.Administering 2 separate vaccines for seasonal and pandemic influenza was necessary in 2009. Therefore, we conducted a randomized trial of monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine) and seasonal trivalent inactivated influenza vaccine (TIV; split virion) given sequentially or concurrently in previously vaccinated children.Methods.Children randomized to 4 study groups and stratified by age received 1 dose of seasonal TIV and 2 doses of 2009 H1N1 vaccine in 1 of 4 combinations. Injections were given at 21-day intervals and serum samples for hemagglutination inhibition antibody responses were obtained prior to and 21 days after each vaccination. Reactogenicity and adverse events were monitored.Results.All combinations of vaccines were safe in the 531 children enrolled. Generally, 1 dose of 2009 H1N1 vaccine and 1 dose of TIV, regardless of sequence or concurrency of administration, was immunogenic in children ≥10 years of age; children <10 years of age required 2 doses of 2009 H1N1 vaccine.Conclusions.Vaccines were generally well tolerated. The immune responses to 2009 H1N1 vaccine were adequate regardless of the sequence of vaccination in all age groups but the sequence affected titers to TIV antigens. Two doses of 2009 H1N1 vaccine were required to achieve a protective immune response in children <10 years of age.Clinical Trials Registration.NCT00943202.

AB - Background.Administering 2 separate vaccines for seasonal and pandemic influenza was necessary in 2009. Therefore, we conducted a randomized trial of monovalent 2009 H1N1 influenza vaccine (2009 H1N1 vaccine) and seasonal trivalent inactivated influenza vaccine (TIV; split virion) given sequentially or concurrently in previously vaccinated children.Methods.Children randomized to 4 study groups and stratified by age received 1 dose of seasonal TIV and 2 doses of 2009 H1N1 vaccine in 1 of 4 combinations. Injections were given at 21-day intervals and serum samples for hemagglutination inhibition antibody responses were obtained prior to and 21 days after each vaccination. Reactogenicity and adverse events were monitored.Results.All combinations of vaccines were safe in the 531 children enrolled. Generally, 1 dose of 2009 H1N1 vaccine and 1 dose of TIV, regardless of sequence or concurrency of administration, was immunogenic in children ≥10 years of age; children <10 years of age required 2 doses of 2009 H1N1 vaccine.Conclusions.Vaccines were generally well tolerated. The immune responses to 2009 H1N1 vaccine were adequate regardless of the sequence of vaccination in all age groups but the sequence affected titers to TIV antigens. Two doses of 2009 H1N1 vaccine were required to achieve a protective immune response in children <10 years of age.Clinical Trials Registration.NCT00943202.

UR - http://www.scopus.com/inward/record.url?scp=84865726229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865726229&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis445

DO - 10.1093/infdis/jis445

M3 - Article

VL - 206

SP - 828

EP - 837

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -